Colin G. Taylor

1.4k total citations
57 papers, 1.1k citations indexed

About

Colin G. Taylor is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Colin G. Taylor has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Hematology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Colin G. Taylor's work include Acute Myeloid Leukemia Research (7 papers), Analytical chemistry methods development (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Colin G. Taylor is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Analytical chemistry methods development (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Colin G. Taylor collaborates with scholars based in United Kingdom, United States and Netherlands. Colin G. Taylor's co-authors include W. Pagé Faulk, Jean Sargent, John A. McIntyre, Christine Williamson, Peter R. McConnachie, Kate Grudpan, Rik J. Scheper, Marc Maliepaard, J. N. Pearce and Chang‐Jing G. Yeh and has published in prestigious journals such as The Lancet, Blood and The Science of The Total Environment.

In The Last Decade

Colin G. Taylor

56 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin G. Taylor United Kingdom 16 394 212 191 185 180 57 1.1k
Su Young Kim South Korea 24 211 0.5× 100 0.5× 87 0.5× 199 1.1× 111 0.6× 40 1.8k
Abraham J. Wilhelm Netherlands 24 439 1.1× 156 0.7× 221 1.2× 311 1.7× 354 2.0× 61 1.7k
A. Loganath Singapore 16 134 0.3× 109 0.5× 22 0.1× 199 1.1× 47 0.3× 56 1.1k
Mohammad Hasan Sheikhha Iran 22 187 0.5× 224 1.1× 107 0.6× 678 3.7× 103 0.6× 133 1.7k
Qin Liu China 20 114 0.3× 84 0.4× 81 0.4× 735 4.0× 283 1.6× 103 1.8k
A Blair United States 17 117 0.3× 290 1.4× 53 0.3× 125 0.7× 288 1.6× 22 1.6k
Birgitta Pettersson Sweden 19 37 0.1× 183 0.9× 73 0.4× 207 1.1× 168 0.9× 35 1.0k
Ruth J. Geller United States 14 95 0.2× 213 1.0× 44 0.2× 303 1.6× 64 0.4× 45 1.3k
Xiaolin Fan United States 16 198 0.5× 78 0.4× 366 1.9× 246 1.3× 252 1.4× 46 1.5k
H. Wesch Germany 21 73 0.2× 56 0.3× 56 0.3× 441 2.4× 204 1.1× 75 1.7k

Countries citing papers authored by Colin G. Taylor

Since Specialization
Citations

This map shows the geographic impact of Colin G. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin G. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin G. Taylor more than expected).

Fields of papers citing papers by Colin G. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin G. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin G. Taylor. The network helps show where Colin G. Taylor may publish in the future.

Co-authorship network of co-authors of Colin G. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Colin G. Taylor. A scholar is included among the top collaborators of Colin G. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin G. Taylor. Colin G. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delft, Frederik W. van, Anthony Bellotti, Naina Patel, et al.. (2003). Gene expression profiling in childhood acute leukaemia; a useful classification tool and a first promising insight into drug resistance.. Blood. 102(11). 1 indexed citations
2.
Coley, Helen M., Jean Sargent, Christine Williamson, et al.. (2002). Assessment of the classical MDR phenotype in epithelial ovarian carcinoma using primary cultures: a feasibility study.. PubMed. 22(1A). 69–74. 5 indexed citations
3.
Sargent, Jean, et al.. (2001). Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562. British Journal of Cancer. 84(7). 959–964. 26 indexed citations
4.
Sargent, Jean, et al.. (2001). Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML. British Journal of Cancer. 84(5). 680–685. 7 indexed citations
5.
Sargent, Jean, et al.. (1999). Aphidicolin Markedly Increases the In Vitro Sensitivity to ARA-C of Blast Cells From Patients with AML. Advances in experimental medicine and biology. 457. 567–570. 5 indexed citations
6.
Sargent, Jean, et al.. (1999). Comparison of P-Glycoprotein Expression and Function with in vitro Sensitivity to Anthracyclines in AML. Advances in experimental medicine and biology. 457. 29–33. 7 indexed citations
7.
Sargent, Jean, et al.. (1999). Comparison of BCL-2 and Bax Protein Expression with in vitro Sensitivity to ARA-C and 6TG in AML. Advances in experimental medicine and biology. 457. 335–340. 9 indexed citations
8.
Sargent, Jean, et al.. (1998). Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML. Leukemia Research. 22(4). 373–378. 21 indexed citations
9.
Taylor, Colin G., et al.. (1998). The Clinical Relevance of Chemosensitivity Testing in Ovarian Cancer. Cancer Detection and Prevention. 22(4). 305–312. 12 indexed citations
10.
Brooks, Daniel J., Colin G. Taylor, A Houghton, et al.. (1995). Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.. PubMed. 1(11). 1259–65. 46 indexed citations
11.
Stasi, Roberto, Colin G. Taylor, Adriano Venditti, et al.. (1995). Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia. Annals of Hematology. 71(1). 13–27. 8 indexed citations
12.
Sargent, Jean, et al.. (1994). In vitro modification of drug resistance in fresh tumor cells from patients with ovarian cancer. Anti-Cancer Drugs. 5. 61–61. 1 indexed citations
13.
Taylor, Colin G., et al.. (1993). Heparin and Pregnancy in Women with a History of Repeated Miscarriages. Pathophysiology of Haemostasis and Thrombosis. 23(Suppl. 1). 202–211. 32 indexed citations
14.
Farrant, J. Mark, Colin G. Taylor, & Stephen Beer. (1988). NEPHROTIC SYNDROME IN CHRONIC LYMPHOCYTIC LEUKAEMIA. British Journal of Haematology. 69(3). 419–419. 5 indexed citations
15.
HILL, N. C. W., et al.. (1988). Effect of low dose heparin on blood loss at caesarean section. BMJ. 296(6635). 1505–1506. 29 indexed citations
16.
Taylor, Colin G., et al.. (1987). Determination of ascorbic acid in multivitamin tablets by thermometric titrimetry with cerium(IV). The Analyst. 112(4). 507–507. 9 indexed citations
17.
McIntyre, John A., Peter R. McConnachie, Colin G. Taylor, & W. Pagé Faulk. (1984). Clinical, immunologic, and genetic definitions of primary and secondary recurrent spontaneous abortions. Fertility and Sterility. 42(6). 849–855. 80 indexed citations
18.
Docherty, Peter, et al.. (1983). The effect of low‐dose heparin on blood loss at abdominal hysterectomy. BJOG An International Journal of Obstetrics & Gynaecology. 90(8). 759–763. 12 indexed citations
19.
Taylor, Colin G. & J. Waters. (1974). Ion-association compounds of anionic surfactants with iron(II) chelates. Analytica Chimica Acta. 69(2). 363–371. 7 indexed citations
20.
Taylor, Colin G. & J. Waters. (1972). Radiometric determination of trace amounts of anionic surfactants in ground water and potable water. The Analyst. 97(1156). 533–533. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026